Eli Lilly and Company (LLY) News Today $776.26 -45.20 (-5.50%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$776.50 +0.24 (+0.03%) As of 05/6/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Eli Lilly and Company (NYSE:LLY) Trading Down 0.3% on Analyst DowngradeMay 7 at 1:23 AM | americanbankingnews.comLilly breaks ground on medicine-making facility of the future in Boone CountyMay 6 at 11:19 PM | msn.comEli Lilly in licensing pact with Alchemab for ALS programMay 6 at 6:18 PM | msn.comLilly breaks ground on $4.5 billion R&D facilityMay 6 at 6:18 PM | msn.comEli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?May 6 at 6:18 PM | finance.yahoo.comEli Lilly Stock Is Sliding Tuesday: What's Going On?May 6 at 4:20 PM | benzinga.comEli Lilly and Company Announces Quarterly Dividend of $1.50 (NYSE:LLY)Eli Lilly and Company (NYSE:LLY) announced a quarterly dividend on Monday, May 5th. Investors of record on Friday, May 16th will be given a dividend of 1.50 per share on Tuesday, June 10th. This represents a $6.00 dividend on an annualized basis and a yield of 0.73%.May 6 at 2:57 PM | marketbeat.comPharmaceutical Stocks To Watch Today - May 5thEli Lilly and Company, Berry Global Group, and Thermo Fisher Scientific are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are equity shares of companies engaged in the research, development, manufacturing and marketing of prescrMay 6 at 2:25 PM | marketbeat.comIs Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Shares of Eli Lilly just got walloped. So, is the company still the name to own in GLP-1s, or are the tables turning on this pharma giant?May 6 at 12:32 PM | marketbeat.comEli Lilly (LLY) Partners with Alchemab on ALS Drug DevelopmentMay 6 at 12:06 PM | gurufocus.comEli Lilly and Company (NYSE:LLY) Trading Down 0.3% Following Analyst DowngradeEli Lilly and Company (NYSE:LLY) Trading Down 0.3% Following Analyst DowngradeMay 6 at 11:14 AM | marketbeat.comMutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling NameMay 6 at 10:21 AM | investors.comEli Lilly and Company Q1 Earnings TranscriptMay 6 at 7:26 AM | marketbeat.com4,000 Shares in Eli Lilly and Company (NYSE:LLY) Bought by Blue Capital Inc.Blue Capital Inc. acquired a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,000 shares of the company's stock, valued at approximatelyMay 6 at 7:25 AM | marketbeat.comBrevan Howard Capital Management LP Reduces Stock Position in Eli Lilly and Company (NYSE:LLY)Brevan Howard Capital Management LP trimmed its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,435 shares of the company's stock after selling 7,340 shares dMay 6 at 7:24 AM | marketbeat.comBulltick Wealth Management LLC Sells 1,637 Shares of Eli Lilly and Company (NYSE:LLY)Bulltick Wealth Management LLC reduced its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 60.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,059 shares of the company's stock after sMay 6 at 7:02 AM | marketbeat.comTrump Sets Pharma Tariffs Deadline. The Fallout for Eli Lilly, Pfizer, Other Drugmakers.May 6 at 6:59 AM | barrons.comCantor Fitzgerald L. P. Acquires New Position in Eli Lilly and Company (NYSE:LLY)Cantor Fitzgerald L. P. bought a new position in Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,546 shares of the company's stock, valued at approximately $3,510,000. SeveralMay 6 at 6:53 AM | marketbeat.comCaptrust Financial Advisors Sells 13,041 Shares of Eli Lilly and Company (NYSE:LLY)Captrust Financial Advisors cut its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 6.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 201,498 shares of the company's stock after selling 13,041 shares during tMay 6 at 6:53 AM | marketbeat.comCary Street Partners Financial LLC Acquires New Position in Eli Lilly and Company (NYSE:LLY)Cary Street Partners Financial LLC bought a new position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 26,339 shares of the company's stock, vaMay 6 at 6:44 AM | marketbeat.comBrown Advisory Inc. Sells 2,105 Shares of Eli Lilly and Company (NYSE:LLY)Brown Advisory Inc. cut its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 106,856 shares of the company's stock after selling 2,105 shares during the quarter. BrownMay 6 at 6:16 AM | marketbeat.comBamco Inc. NY Sells 3,000 Shares of Eli Lilly and Company (NYSE:LLY)Bamco Inc. NY reduced its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 13.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,000 shares of the company's stock after selling 3,0May 6 at 5:58 AM | marketbeat.comBenjamin Edwards Inc. Increases Position in Eli Lilly and Company (NYSE:LLY)Benjamin Edwards Inc. increased its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 13.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,265 shares of the company's stock after bMay 6 at 5:33 AM | marketbeat.comAlgert Global LLC Increases Stake in Eli Lilly and Company (NYSE:LLY)Algert Global LLC lifted its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,258 shares of the company's stock after buying an additional 1,May 6 at 5:24 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Given Average Recommendation of "Moderate Buy" by AnalystsEli Lilly and Company (NYSE:LLY - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-one ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recoMay 6 at 2:35 AM | marketbeat.comPharmaceutical Stocks To Watch Today - May 4thEli Lilly and Company, Becton, Dickinson and Company, Abbott Laboratories, AbbVie, and Amgen are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture and marketMay 5 at 4:05 PM | marketbeat.comMedical Stocks To Consider - May 4thEli Lilly and Company, UnitedHealth Group, Hims & Hers Health, Becton, Dickinson and Company, and Walmart are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector—ranging fromMay 5 at 2:01 PM | marketbeat.comEli Lilly announces $1.50 Q2 dividend per shareMay 5 at 1:16 PM | investing.comEli Lilly declares $1.50 dividendMay 5 at 12:53 PM | seekingalpha.comLilly declares second-quarter 2025 dividendMay 5 at 12:47 PM | prnewswire.comWith compounders out of the way, Lilly and Novo go after each otherMay 5 at 11:29 AM | finance.yahoo.comBW Gestao de Investimentos Ltda. Purchases New Holdings in Eli Lilly and Company (NYSE:LLY)BW Gestao de Investimentos Ltda. acquired a new position in Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 3,800 shares of the company's stock, valued atMay 5 at 7:30 AM | marketbeat.comBaird Financial Group Inc. Lowers Stock Holdings in Eli Lilly and Company (NYSE:LLY)Baird Financial Group Inc. cut its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 263,047 shares of the company's stock after selliMay 5 at 7:21 AM | marketbeat.comBaldwin Investment Management LLC Has $6.86 Million Holdings in Eli Lilly and Company (NYSE:LLY)Baldwin Investment Management LLC raised its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 6.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 8,887 shares of the company's stock after purchasing an additional 533 shares during theMay 5 at 6:51 AM | marketbeat.com138,230 Shares in Eli Lilly and Company (NYSE:LLY) Acquired by Banque Transatlantique SABanque Transatlantique SA acquired a new position in Eli Lilly and Company (NYSE:LLY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 138,230 shares of the company's stockMay 5 at 6:49 AM | marketbeat.com3 No-Brainer Stocks to Buy in MayMay 5 at 6:45 AM | fool.comBeck Bode LLC Sells 16,538 Shares of Eli Lilly and Company (NYSE:LLY)Beck Bode LLC cut its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 98.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 346 shares of the company's stock after selling 16,538May 5 at 6:40 AM | marketbeat.comBellevue Group AG Purchases 1,219 Shares of Eli Lilly and Company (NYSE:LLY)Bellevue Group AG raised its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,465 shares of the company's stock after acquiring an additional 1,219May 5 at 6:32 AM | marketbeat.comBearing Point Capital LLC Invests $1.92 Million in Eli Lilly and Company (NYSE:LLY)Bearing Point Capital LLC bought a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,486 shares of the company's stock, valued at approximately $1,9May 5 at 5:59 AM | marketbeat.comBNP Paribas Trims Stake in Eli Lilly and Company (NYSE:LLY)BNP Paribas lessened its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 14.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,628 shares of the company's stock after selling 5,892 shares dMay 5 at 5:49 AM | marketbeat.comEli Lilly’s Strategic Adjustments and Growth Prospects Reinforce Buy Rating Despite SetbacksMay 5 at 5:31 AM | tipranks.comLeerink Partnrs Brokers Reduce Earnings Estimates for LLYMay 5 at 1:42 AM | americanbankingnews.comLeerink Partnrs Has Negative Outlook for LLY Q2 EarningsEli Lilly and Company (NYSE:LLY - Free Report) - Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of Eli Lilly and Company in a report released on Thursday, May 1st. Leerink Partnrs analyst D. Risinger now forecasts that the company will postMay 5 at 1:40 AM | marketbeat.comPharmaceutical Stocks To Research - May 3rdEli Lilly and Company, Becton, Dickinson and Company, Abbott Laboratories, AbbVie, and Amgen are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and markeMay 4 at 4:02 PM | marketbeat.comMedical Stocks To Watch Today - May 3rdEli Lilly and Company, UnitedHealth Group, Hims & Hers Health, Becton, Dickinson and Company, Walmart, Stryker, and Abbott Laboratories are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in theMay 4 at 2:02 PM | marketbeat.comAlteri Wealth LLC Takes Position in Eli Lilly and Company (NYSE:LLY)Alteri Wealth LLC purchased a new position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,991 shares of the company's stock, vMay 4 at 7:35 AM | marketbeat.comAmeriServ Wealth Advisors Acquires New Shares in Eli Lilly and Company (NYSE:LLY)AmeriServ Wealth Advisors purchased a new position in Eli Lilly and Company (NYSE:LLY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,181 shares of the company's stock, valued at approxiMay 4 at 7:27 AM | marketbeat.comAptus Capital Advisors LLC Increases Stock Holdings in Eli Lilly and Company (NYSE:LLY)Aptus Capital Advisors LLC increased its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 24.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,180 shares of the company's stock after buMay 4 at 7:13 AM | marketbeat.comAristotle Atlantic Partners LLC Purchases 15,608 Shares of Eli Lilly and Company (NYSE:LLY)Aristotle Atlantic Partners LLC raised its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 61.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,177 shares of the company's stock after purchasiMay 4 at 7:02 AM | marketbeat.comAspire Growth Partners LLC Takes $891,000 Position in Eli Lilly and Company (NYSE:LLY)Aspire Growth Partners LLC purchased a new position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 1,154 shares of the company's stock, valued atMay 4 at 6:39 AM | marketbeat.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼0.740.69▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼15077▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LLY Stock Free LLY Stock Alerts